BTK Inhibitors in the Management of Lymphoma

BTK Inhibitors in the Management of Lymphoma

obr

3 months
4 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Michael Wang, MD, Professor, Department of Lymphoma and Myeloma @MDAndersonNews offers his opinion on zanubrutinib as compared to other second-generation BTK inhibitors in the management of lymphoma.

Up Next Autoplay